OctoPlus' Licensee Biolex Commences Phase IIb Study with Locteron

News   Apr 22, 2009

 
OctoPlus' Licensee Biolex Commences Phase IIb Study with Locteron
 
 
 

RELATED ARTICLES

Antimalarial Drugs Could Offer Clinical Benefit to Cancer Patients

News

Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.

READ MORE

Chemists Design More Efficient Microreactor Using 3D Printing

News

Researchers developed an electrochemical microreactor using additive manufacturing technology (commonly known as 3D printing). The newly developed microreactor was tested on synthesis of isoindolinones, which are found in many natural products, pharmaceuticals, and biologically active molecules.

READ MORE

Novel Chemistry Technique Simplifies Late-Stage Modification of Drug Compounds

News

Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE